Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
Titel:
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
Auteur:
Geoerger, Birgit Kang, Hyoung Jin Yalon-Oren, Michal Marshall, Lynley V Vezina, Catherine Pappo, Alberto Laetsch, Theodore W Petrilli, Antonio S Ebinger, Martin Toporski, Jacek Glade-Bender, Julia Nicholls, Wayne Fox, Elizabeth DuBois, Steven G Macy, Margaret E Cohn, Susan L Pathiraja, Kumudu Diede, Scott J Ebbinghaus, Scot Pinto, Navin